Deferiprone‐induced agranulocytosis: 20 years of clinical observations-Reference-Cited by-同舟云学术

Deferiprone‐induced agranulocytosis: 20 years of clinical observations

Published:2016-08-04 Issue:10 Volume:91 Page:1026-1031
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Tricta Fernando¹,Uetrecht Jack²,Galanello Renzo³,Connelly John¹,Rozova Anna¹,Spino Michael¹,Palmblad Jan⁴

Affiliation:

1. ApoPharma IncToronto Ontario Canada

2. Leslie Dan Faculty of PharmacyUniversity of TorontoToronto Ontario Canada

3. Ospedale Regionale per la Microcitemia, ASL8, Cagliari Italy

4. Departments of Medicine and HematologyKarolinska Institutet, Karolinska University Hospital HuddingeStockholm Sweden

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.24479

Reference35 articles.

1. Deferiprone Chelation Therapy for Thalassemia Major

2. ApoPharma Inc. Ferriprox® US Prescribing Information (PI).http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021825lbl.pdf

3. ApoPharma Inc. Ferriprox® (Deferiprone) Summary of Product Characteristics (SmPC).http://ec.europa.eu/health/documents/communityregister/html/h108.htm.

4. Agranulocytosis due to deferiprone: A case report with cytomorphological and functional bone marrow examination;Masera N;Blood Transfus,2011

5. Continuation of deferiprone therapy in patients with mild neutropenia may not lead to a more severe drop in neutrophil count

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disproportionality analysis of data from VigiBase and other global product safety databases on toxicity of iron chelating agents;Expert Opinion on Drug Safety;2024-08

2. Diagnosis, treatment, and surveillance of Diamond-Blackfan anaemia syndrome: international consensus statement;The Lancet Haematology;2024-05

3. Real‐world evidence: Long‐term safety of deferiprone in a large cohort of patients with sickle cell disease enrolled in a registry for up to 10 years;American Journal of Hematology;2024-03

4. Challenges of Iron Chelation in Thalassemic Children;Thalassemia Reports;2024-02-01

5. Deferoxamine and other iron chelators;Encyclopedia of Toxicology;2024